6: Episode 6: Approval of Oral Semaglutide and PIONEER Trials with Dr. Aroda
The approval of oral semaglutide, an oral GLP-1 receptor agonist, could mark the beginning of a new era in the treatment of diabetes. We sat down with PIONEER investigator Vanita Aroda, MD, of Brigham and Women's, to learn more about the impact of this approval.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.